FTSE MIB
34.249,77 +310,02 (+0,91%) Dow Jones
38.281,48 +195,68 (+0,51%) Nasdaq
15.947,00 +335,24 (+2,15%) Nikkei 225
37.934,76 +306,28 (+0,81%) Petrolio
84,03 +0,46 (+0,55%) Bitcoin EUR
59.492,37 -487,52 (-0,81%)
ZIVO Bioscience, Inc. (ZIVO)
| Chiusura precedente | 8,00 |
| Aperto | 7,00 |
| Denaro | 0,00 x 800 |
| Lettera | 0,00 x 1100 |
| Min-Max giorno | 7,00 - 8,10 |
| Intervallo di 52 settimane | 0,48 - 19,08 |
| Volume | |
| Media Volume | 1.966 |
| Capitalizzazione | 22,499M |
| Beta (5 anni mensile) | 0,27 |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | -4,60 |
| Prossima data utili | 10 mag 2024 - 14 mag 2024 |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | 12,00 |
GlobeNewswireZIVO Bioscience to Present at the Dawson James Small Cap Growth Conference
BLOOMFIELD HILLS, Mich, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Zivo Bioscience, Inc. (NASDAQ: ZIVO) (the “Company”), a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, announces that management will deliver a company presentation and will hold investor meetings at the 8th Annual Dawson James Small Cap Growth Conference being held Thursday, October 12, 2023 at the Wyndham Grand Jupiter at Harbour
GlobeNewswireDawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference
JUPITER, Fla., Sept. 21, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- Dawson James Securities, Inc. (“Dawson”), a full-service investment bank focused on emerging growth companies, today announces its 8th Annual Dawson James Small Cap Growth Conference on October 12, 2023, at the Wyndham Grand Hotel in Jupiter, FL. Dawson James’ flagship Small Cap Growth Conference brings together senior leadership from over 30 of the most innovative companies at the forefront of healthcare, technology and consu
